Finer Focus | GenomeWeb

Finer Focus

PARP inhibitors were all but written off a few years ago, but now are back with a focus on BRCA1 and BRCA2 mutation-related cancers, the Wall Street Journal reports.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.